The Pharma Data

FEBRUARY 1, 2021

01, 2021 (GLOBE NEWSWIRE) — Biogen Inc. The addition of the IM administration of Plegridy to Biogen’s MS portfolio offers another important option at a time when MS patients are being encouraged to discuss their MS treatment and considerations around COVID-19 vaccination with their physicians.1,2 CAMBRIDGE, Mass.,

FDA Approval 40

FDA Approval FDA Clinical Trials Biosimilars 40

The Pharma Data

MAY 15, 2023

Huebscher , non-executive board member in companies, institutions and former CEO of Solvias Group, a Swiss contract research firm, which she led between 2014 and 2021. Remco Steenbergen, Chief Financial Officer of Deutsche Lufthansa AG since 2021, the largest airline group in Europe with approximately EUR 33 billion of sales in 2022.

Science 40

Science Doctors Government Compliance 40

The Pharma Data

JANUARY 26, 2021

27, 2021 10:02 UTC. Reddy’s”) and Global Response Aid FZCO (GRA) today announced the termination of Avigan Trial Study conducted in Kuwait focused on moderate to severe COVID patients in a hospital setting. The full data analysis on 353 subjects would be available by the end of February 2021.

Hospitals 40

Hospitals Laboratories Pharmaceuticals Production 40

The Pharma Data

APRIL 27, 2021

Paris, April 28, 2021. Strong increase in Q1 2021 business EPS ( 1) at CER. Q1 2021 sales increase of 2.4% at CER driven by growth drivers Dupixent ® and Vaccines. Vaccines up 5.3%, driven by PPH franchise and demand for influenza vaccines in southern hemisphere. Sanofi continued its growth trajectory.

Vaccine 52

Vaccine Production FDA FDA Approval 52

The Pharma Data

FEBRUARY 8, 2021

Across clinical trials (PALOMA-1, PALOMA-2, PALOMA-3), 1.0% Today, we have an industry-leading portfolio of 24 approved innovative cancer medicines and biosimilars across more than 30 indications, including breast, genitourinary, colorectal, blood and lung cancers, as well as melanoma.

Clinical Trials 52

Clinical Trials Treatment Therapies Production 52

Agency IQ

JUNE 2, 2023

In 2022 and 2021, the Spring Unified Agenda was released in early/mid June. 6/27/2023 Notification FDORA, Section 3201 Within 180 days of the passage of FDORA, all biologics and biosimilars sponsors must submit a written notice to the FDA of all actively marketed products (i.e., not discontinued) and are available for sale.

FDA 40

FDA Science Regulations Production 40

Agency IQ

OCTOBER 6, 2023

As such, it doesn’t review things like vaccines, blood products or gene therapies – those products are instead reviewed by CBER. For example, these products face a much more arduous path for development of biosimilar or interchangeable products than that of generics for small molecules. Read the AgencyIQ analysis here.

FDA 52

FDA Biosimilars Science Production 52

The Pharma Data

JULY 21, 2021

Pharmaceuticals Division sales decline 3%; sales grow 4% in the second quarter, following a first-quarter decrease of 9%; newly launched medicines (+30%) compensate for the continued impact from biosimilars. Outlook for 2021 confirmed. Based on the good results of the first half of 2021, we confirm the outlook for the full year.”.

Biosimilars 52

Biosimilars Pharmaceuticals FDA Disease 52

The Pharma Data

FEBRUARY 8, 2021

Vaccines up 14.6%, driven by record demand for differentiated influenza vaccines and continued growth of PPH. to €36,041 million, driven by Dupixent ® (€3,534 million, up 73,9%) and Vaccines. 2021 financial outlook. Q4 2020 sales growth (2) of 4.2% and business EPS growth of 9.8% to €982 million). Sales down 2.4%

Vaccine 52

Vaccine Production FDA Pharmaceuticals 52

The Pharma Data

FEBRUARY 4, 2021

Vaccines up 14.6%, driven by record demand for differentiated influenza vaccines and continued growth of PPH. to €36,041 million, driven by Dupixent ® (€3,534 million, up 73,9%) and Vaccines. 2021 financial outlook. Q4 2020 sales growth (2) of 4.2% and business EPS growth of 9.8% to €982 million). Sales down 2.4%

Vaccine 52

Vaccine Production FDA Pharmaceuticals 52

The Pharma Data

MAY 4, 2021

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS. Tue, 05/04/2021 – 06:45. Tuesday, May 04, 2021 – 06:45am. <!–*/. First-Quarter 2021 Revenues of $14.6 First-Quarter 2021 Reported Diluted EPS (1) of $0.86, Adjusted Diluted EPS (2) of $0.93. Anonymous (not verified). –*/. <!–*/.q4default.bwalignc

Vaccine 40

Vaccine Production FDA Clinical Trials 40

The Pharma Data

JULY 8, 2021

We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. PFIZER DISCLOSURE NOTICE: The information contained in this release is as of July 8, 2021.

Disease 52

Disease Government Clinical Trials Research 52

Agency IQ

SEPTEMBER 29, 2023

Due to the presence of nitrosamines in certain drug products, FDA had required that drug manufacturers conduct an initial risk assessment of approved or marketed products, with an initial completion date of October 1, 2021, and then confirmatory testing due by October 1, 2023.

FDA 40

FDA Science Regulations Production 40

The Pharma Data

MAY 14, 2021

Posted 14 May 2021 | By Michael Mezher . Fully vaccinated people can shed their masks in most places – CDC ( Reuters ) ( STAT ). US diplomats: Send vaccine overseas now or China, Russia will win out ( Politico ). J&J pushes Latin America to take unfrozen vaccines in Covax talks ( FT ).

FDA 52

FDA Therapies Vaccine Biosimilars 52

The Pharma Data

MAY 3, 2021

Posted 03 May 2021 | By Michael Mezher . Feds rethink vaccination strategy as slowing demand reveals stark divide ( Politico ). US to launch trade talks on COVID-19 vaccine distribution ( AP ) ( CNBC ). Next Generation of Covid-19 Vaccines Could Be Pill or Spray ( WSJ ). Mass.

Vaccine 52

Vaccine Biosimilars FDA Regulations 52

Drug Hunter

APRIL 24, 2023

Due to elimination of out of pocket patient costs for vaccines covered by Medicare/Medicaid access to adult vaccines will improve. million Medicare beneficiaries received a vaccine in 2022 and half of states did not cover all vaccines recommended by the Advisory Committee on Immunization Practices. For perspective, 4.1

Small Molecule 130

Small Molecule Biosimilars Drugs Vaccine 130

The Pharma Data

MAY 17, 2021

Posted 17 May 2021 | By Michael Mezher . Covid-19 Drugmakers Take On Your Favorite TV Shows to Tackle Vaccine Hesitancy ( WSJ ). Regeneron resumes enrollment in lymphoma drug trials ( Reuters ). Incyte’s vitiligo treatment meets main goal in late-stage trial ( Reuters ).

Trials 52

Trials Vaccine FDA Biosimilars 52